Raymond James analyst Rahul Sarugaser is feeling confident in Ginkgo Bioworks Holdings (Ginkgo Bioworks Stock Quote, Chart, News NYSE:DNA), maintaining his “Outperform 2” rating and target price of $11.50/share for a projected return of 385.2 per cent in an update to clients on Tuesday. Boston-based Ginkgo Bioworks builds bespoke living cells through the use of […]
Douglas Loe of Leede Jones Gable is not loving what he’s seeing from Liminal Biosciences (Liminal Biosciences Stock Quote, Charts, News, Analysts, Financials NASDAQ:LMNL), maintaining a “Hold” rating and dropping his target price from $2.50/share to $2/share (all figures in this article are in US dollars) with any return listed as not available in an […]
Share
Tweet
Share
